ENB Therapeutics
  • Home
  • About
  • Pipeline
  • News/Blog
  • Contact Us
Select Page

ENB Lead Product ENB001 Awarded Orphan Drug Designation by the FDA

by admin | Jan 30, 2016 | Uncategorized

January 21,2016- FDA awards ENB lead product ENB001 Orphan Drug Designation for Stage IIB- Stage IV melanoma. This represents a major milestone in our development program for ENB001 which now qualifies for various development incentives including tax credits for...

ENB is invited to give a presentation at the 2016 Biotech Showcase

by admin | Jan 9, 2016 | Uncategorized

December, 2015. Biotech Showcase™ is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during...

Life Sciences Summit 2016 invites ENB to be a pipeline cafe participant

by admin | Jan 9, 2016 | Uncategorized

November, 2015 The Life Sciences Summit is an early stage investor and business development conference that highlights innovation. The pipeline café features academic innovators who are hand selected to present their discoveries, which are available for partnering....

Recent Posts

  • ENB Therapeutics Demonstrated Early Efficacy in Phase I Clinical Trial of ENB-003 in Combination with Pembrolizumab
  • Early efficacy signals in ovarian cancer patients in ongoing Ph1 trial: Poster reporting findings presented at SITC 2020 Annual Meeting
  • ENB Therapeutics Announces Successful Completion of the First Dosing Cohort in Phase 1 Clinical Trial of ENB-003 in Combination with Pembrolizumab
  • IND approval received for lead product ENB-003
  • ENB Therapeutics Announces Clinical Trial Collaboration with Merck to Evaluate ENB-003 in combination with KEYTRUDA® (pembrolizumab) for Advanced Solid Tumors

Archives

  • February 2021
  • November 2020
  • February 2019
  • September 2018
  • April 2016
  • January 2016
  • June 2015

Categories

  • Press Releases
  • Uncategorized

Explore

  • Home
  • About
  • Pipeline
  • News/Blog
  • Contact Us

Recent Posts

Click Here

ENB Therapeutics
Alexandria Center For Life Sciences,
Launch Labs
430 E 29th Street, 14th Floor
New York, NY 10016
(212) 792-2317
info@enbpharma.com

Designed by Elegant Themes | Powered by WordPress